News

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) ...
Peter DeYoung, CEO at Piramal Pharma Limited, explains how Piramal is meeting the growing demand for integrated biologics ...
Pharmaceutical Technology® spoke with Martin Meeson, CEO of Axplora, about the role contract development and manufacturing ...
Teva’s investigational monoclonal antibody, TEV-53408, has been designed for use in adults with celiac disease, for which a ...
Both companies viewed the early end to the PIVOT-PO trial as a positive development, with GSK saying it would work with US ...
In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, ...
Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts ...
Global scale-up requires developing replicable processes that work the same no matter where they are performed. This can be ...
Christy Eatmon of Thermo Fisher Scientific reviewed her company’s experience at CPHI Americas 2025 and discussed recent industry trends that are driving strategic partnerships.
Israel Ortíz is vice president and general manager at Accruent.
Leveraging computerized maintenance management systems software can enhance efficiency, improve quality control, ensure ...
MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients.